WAY-100635 is a potent dopamine D₄ receptor agonistCHEMEL, Benjamin R; ROTH, Bryan L; ARMBRUSTER, Blaine et al.Psychopharmacologia. 2006, Vol 188, Num 2, pp 244-251, issn 0033-3158, 8 p.Article

Effects of 8-OH-DPAT and WAY-100635 on performance on a time-constrained progressive-ratio scheduleHO, M.-Y; BODY, S; KHERAMIN, S et al.Psychopharmacologia. 2003, Vol 167, Num 2, pp 137-144, issn 0033-3158, 8 p.Article

WAY-100635 has high selectivity for serotonin 5-HT_1A versus dopamine D₄ receptorsMARTEL, Jean-Claude; LEDUC, Nathalie; ORMIERE, Anne-Marie et al.European journal of pharmacology. 2007, Vol 574, Num 1, pp 15-19, issn 0014-2999, 5 p.Article

Determination of metabolic stability of positron emission tomography tracers by LC-MS/MS : An example in WAY-100635 and two analoguesLAVEN, M; ITSENKO, O; MARKIDES, K et al.Journal of pharmaceutical and biomedical analysis. 2006, Vol 40, Num 4, pp 943-951, issn 0731-7085, 9 p.Article

The roles of 5-HT_1A and 5-HT ₂ receptors in the effects of 5-MeO-DMT on locomotor activity and prepulse inhibition in ratsKREBS-THOMSON, Kirsten; RUIZ, Erbert M; MASTEN, Virginia et al.Psychopharmacologia. 2006, Vol 189, Num 3, pp 319-329, issn 0033-3158, 11 p.Article

Evidence that the 5-HT_1A autoreceptor is an important pharmacological target for the modulation of cocaine behavioral stimulant effectsCAREY, Robert J; DEPALMA, Gail; DAMIANOPOULOS, Ernest et al.Brain research. 2005, Vol 1034, Num 1-2, pp 162-171, issn 0006-8993, 10 p.Article

A pharmacological profiles of the selective silent 5-HT_1A receptor antagonist, WAY-100635FORSTER, E. A; CLIFFE, I. A; BILL, D. J et al.European journal of pharmacology. 1995, Vol 281, Num 1, pp 81-88, issn 0014-2999Article

8 -hydroxy -2 -(di -n -propylamino ) -tetralin inhibits food intake in fasted rats by an action at 5-HT_1A receptorsEBENEZER, I. S; ARKLE, M. J; TITE, R. M et al.Methods and findings in experimental and clinical pharmacology. 2007, Vol 29, Num 4, pp 269-272, issn 0379-0355, 4 p.Article

Descending facilitation of spinal NMDA-dependent reflex potentiation from pontine tegmentum in ratsCHEN, Gin-Den; PENG, Hsien-Yu; TUNG, Kwong-Chung et al.American journal of physiology. Renal physiology. 2007, Vol 62, Num 4, issn 1931-857X, F1115-F1122Article

In the formalin model of tonic nociceptive pain, 8-OH-DPAT produces 5-HT_1A receptor-mediated, behaviorally specific analgesiaBARDIN, Laurent; TARAYRE, Jean-Pierre; KOEK, Wouter et al.European journal of pharmacology. 2001, Vol 421, Num 2, pp 109-114, issn 0014-2999Article

WAY-100635 inhibits 8-OH-DPAT-stimulated oxytocin, ACTH and corticosterone, but not prolactin secretionVICENTIC, A; QIAN LI; BATTAGLIA, G et al.European journal of pharmacology. 1998, Vol 346, Num 2-3, pp 261-266, issn 0014-2999Article

Characterisation of the binding of [³H]WAY-100635, a novel 5-hydroxytryptamine_1A receptor antagonist, to rat brainKHAWAJA, X; EVANS, N; REILLY, Y et al.Journal of neurochemistry. 1995, Vol 64, Num 6, pp 2716-2726, issn 0022-3042Article

Parametric and regional maps of free serotonin 5HT_IA receptor sites in human brain as function of age in healthy humansMOLLER, Mette; JAKOBSEN, Steen; GJEDDE, Albert et al.Neuropsychopharmacology (New York, NY). 2007, Vol 32, Num 8, pp 1707-1714, issn 0893-133X, 8 p.Article

Serotonin-induced enhancement of vasopressin and oxytocin secretion in rat neurohypophyseal tissue cultureGALFI, M; RADACS, M; JUHASZ, A et al.Regulatory peptides. 2005, Vol 127, Num 1-3, pp 225-231, issn 0167-0115, 7 p.Article

Anxiolytic-like effects of the selective 5-HT_1A receptor antagonist WAY 100635 in non-human primatesBARROS, Marilia; MELLO, Eldon L; MAIOR, Rafael S et al.European journal of pharmacology. 2003, Vol 482, Num 1-3, pp 197-203, issn 0014-2999, 7 p.Article

Additive reduction of alcohol drinking by 5-HT_1A antagonist WAY 100635 and serotonin uptake blocker fluoxetine in alcohol-preferring P ratsZHOU, F. C; MCKINZIE, D. L; PATEL, T. D et al.Alcoholism, clinical and experimental research. 1998, Vol 22, Num 1, pp 266-269, issn 0145-6008Conference Paper

Reversal of visual attention dysfunction after AMPA lesions of the nucleus basalis magnocellularis (NBM) by the cholinesterase inhibitor donepezil and by a 5-HT_1A receptor antagonist WAY 100635BALDUCCI, C; NURRA, M; PIETROPOLI, A et al.Psychopharmacologia. 2003, Vol 167, Num 1, pp 28-36, issn 0033-3158, 9 p.Article

Cocaine conditioning : Reversal by autoreceptor dose levels of 8-OHDPATCAREY, Robert J; DAMIANOPOULOS, Ernest N; SHANAHAN, Arielle B et al.Pharmacology, biochemistry and behavior. 2009, Vol 91, Num 3, pp 447-452, issn 0091-3057, 6 p.Article

The involvement of serotonergic system in the antidepressant effect of zinc in the forced swim testSZEWCZYK, Bernadeta; POLESZAK, Ewa; BRANSKI, Piotr et al.Progress in neuro-psychopharmacology & biological psychiatry. 2009, Vol 33, Num 2, pp 323-329, issn 0278-5846, 7 p.Article

Reactivity of 5-HT_1A receptor in adult rats after neonatal noradrenergic neurons' lesion -Implications for antidepressant-like actionDABROWSKA, Joanna; NOWAK, Przemyslaw; BRUS, Ryszard et al.Brain research. 2008, Vol 1239, pp 66-76, issn 0006-8993, 11 p.Article

Measurement of serotonin 5-HT1A receptor binding using positron emission tomography and [carbonyl-¹¹ C]WAY-100635 : considerations on the validity of cerebellum as a reference regionHIRVONEN, Jussi; KAJANDER, Jaana; ALLONEN, Topias et al.Journal of cerebral blood flow and metabolism. 2007, Vol 27, Num 1, pp 185-195, issn 0271-678X, 11 p.Article

Lack of effect of the 5-HT_1A receptor antagonist WAY-100635 on murine agonistic behaviourBELL, R; LYNCH, K; MITCHELL, P et al.Pharmacology, biochemistry and behavior. 1999, Vol 64, Num 3, pp 549-554, issn 0091-3057Conference Paper

WAY100635-induced augmentation of the 5-HT-elevating action of citalopram : Relative importance of the dose of the 5-HT_1A (auto)receptor blocker versus that of the 5-HT reuptake inhibitorHJORTH, S; WESTLIN, D; BENGTSSON, H. J et al.Neuropharmacology. 1997, Vol 36, Num 4-5, pp 461-465, issn 0028-3908Article

Autoreceptor antagonists enhance the effect of the reuptake inhibitor citalopram on extracellular 5-HT: this effect persists after repeated citalopram treatmentGUNDLAH, C; HJORTH, S; AUERBACH, S. B et al.Neuropharmacology. 1997, Vol 36, Num 4-5, pp 475-482, issn 0028-3908Article

Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT_1A receptor antagonistFLETCHER, A; FORSTER, E. A; CHILDS, K. J et al.Behavioural brain research. 1995, Vol 73, Num 1-2, pp 337-353, issn 0166-4328Conference Paper